- Research Article
2
- 10.1016/j.fhj.2024.100022
Surfing stress: A practical and paradigm changing approach to improving personal resilience
- Mar 01, 2024
- Future Healthcare Journal
- Ashish Bhatia
Publications from 2021 to 2026
Showing 10 of 91 papers
Surfing stress: A practical and paradigm changing approach to improving personal resilience
“It’s crucial they’re treated as patients”: ethical guidance and empirical evidence regarding treating doctor–patients
Ethical guidance from the British Medical Association (BMA) about treating doctor–patients is compared and contrasted with evidence from a qualitative study of general practitioners (GPs) who have been patients. Semistructured interviews were conducted with 17 GPs who had experienced a significant illness. Their experiences were discussed and issues about both being and treating doctor–patients were revealed. Interpretative phenomenological analysis was used to evaluate the data. In this article data extracts are used to illustrate and discuss three key points that summarise the BMA ethical guidance, in order to develop a picture of how far experiences map onto guidance. The data illustrate and extend the complexities of the issues outlined by the BMA document. In particular, differences between experienced GPs and those who have recently completed their training are identified. This analysis will be useful for medical professionals both when they themselves are unwell and when they treat doctor–patients. It will also inform recommendations for professionals who educate medical students or trainees.
Read moreTriad: diabetic ketoacidosis, elevated liver enzymes and abdominal pain— think liver infarct!
A 53-year-old female with type 1 diabetes mellitus for 48 years was admitted with diabetic ketoacidosis (DKA) due to pneumonia. She had had poor diabetic control with multiple previous hospital admissions for hyperglycaemia or DKA and an HbA1c of 8.6%. She had treated, controlled dyslipidaemia and hypertension, a femoral-popliteal arterial bypass graft, gastroparesis and continued to smoke cigarettes. She also had a raised creatinine (160µmol/L) on admission that worsened in spite of treatment for DKA. The patient deteriorated further over the next few days requiring transfer to intensive care (ICU) despite treatment of DKA and pneumonia as per protocol. After 18 days, she complained of severe abdominal pain but further details were sketchy since she was on respiratory support. There was diffuse abdominal tenderness on examination. Abdominal ultrasound showed generalised hepatic hyperechogenicity sparing the caudate lobe, which was thought to be a fatty liver. Liver function tests were abnormal with AST 1530iu/L (normal range 6–36), alkaline phosphatase 723iu/L (NR 20–120) and bilirubin 9mmol/L (NR <17). CT abdomen (Figure 1) revealed infarcted liver. Liver infarct (arrowed) shown on CT scan of the patient's abdomen Despite aggressive treatment of her multi-organ failure including renal failure, adult respiratory distress syndrome, and an ischaemic leg treated by amputation, the patient died 20 days after admission. Hepatic infarction due to arterial insufficiency (to be distinguished from the Zahn infarction of pure portal venous obstruction and the Budd Chiari syndrome of hepatic vein thrombosis) is extremely rare due to the dual blood supply of the liver with both the hepatic artery and portal vein supply. It is thought that impairment of both these vessels is needed to cause hepatic infarction. In a series of 5420 consecutive autopsies, there were only 20 liver infarcts, and 85% of these had had both portal venous thrombosis plus systemic hypotension to reduce the hepatic arterial flow;1 our subject had needed inotropes since admission to ICU but, on the day preceding the abdominal pain, she had become hypotensive requiring an increased dose of inotropes. In the autopsy series, only 10% of subjects had combined thrombosis of hepatic artery and portal vein, and these were both iatrogenic. Most described cases of hepatic infarct were either due to trauma (accidental or surgical),2-5 or associated with atherothrombotic states such as sepsis, pregnancy, intrinsic clotting abnormalities or atherosclerosis. The first case of hepatic infarction associated with DKA, diagnosed with angiogram, isotope liver scan, and biopsy, was apparently reported in 19776 and 1978.7 In 1990, further cases of hepatic infarction were reported in diabetic patients.1, 8, 9Although varied, presenting symptoms largely included abdominal pain and elevated serum transaminases. The confirmation of hepatic infarction has been made by hepatectomy, biopsy, or clinical course compatible with infarction with angiographic or surgical evidence of hepatic arterial abnormality.10 However, a recent series has suggested that CT is the modality of choice for imaging of hepatic infarction, providing useful information regarding site, morphology, and extent of the lesion;11 indeed, in our case, the infarct was seen on CT, but not ultrasound. In most reported cases, patients made an uneventful recovery with treatment of underlying causes or anticoagulants in cases of portal or arterial occlusions. It is not known whether prophylactic heparin or full anticoagulation would avoid the development of hepatic infarction; in our case, the patient received full anticoagulation for the first 10 days in an attempt to save the leg, but none after the amputation. Further imaging of survivors has shown no sequelae. Our patient exhibited multiple risk factors for hepatic infarction including poorly controlled diabetes mellitus, DKA, atherosclerosis, hypotension and hypercoagulable state due to severe sepsis. Although outcomes are normally good, our patient's multi-organ failure leading to the hepatic infarction was always likely to prove fatal. There is a paucity of reports of hepatic infarction in diabetes in the literature which makes us believe that it is rare, but is it so rare? Patients admitted for DKA often complain of non-specific abdominal discomfort or pain, which generally resolves with treatment of DKA; hepatic infarction rarely features in our clinical differential diagnosis, and the diagnosis is frequently reached when patients are investigated for other causes of abdominal pain. We suggest that hepatic infarction is a diagnosis that should be actively considered in diabetic patients with elevated liver enzymes presenting with abdominal pain. Early diagnosis and initiation of treatment are often rewarded with a good outcome, although no randomised controlled trials validate this. We are grateful for the expert radiological assistance of Dr Paul Davison. Practical Diabetes International invites you to submit your favourite slide with clinical details for possible publication in this series.
Read moreLetter to the editor
Journal of Human Nutrition and DieteticsVolume 19, Issue 6 p. 453-454 Letter to the editor Julie Barker, Julie Barker Senior Dietitian, Bristol General Hospital Guinea Street Bristol BS30 8BE E-mail: [email protected]Search for more papers by this author Julie Barker, Julie Barker Senior Dietitian, Bristol General Hospital Guinea Street Bristol BS30 8BE E-mail: [email protected]Search for more papers by this author First published: 10 November 2006 https://doi.org/10.1111/j.1365-277X.2006.00731.xCitations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume19, Issue6December 2006Pages 453-454 RelatedInformation
Read more男性患者に対する硬性膀胱鏡前処置としての尿道内局所麻酔薬ゼリー注入の有用性に関する検討
The analgetic efficacy of intraurethral instillation of anesthetic jelly in rigid cystoscopic examination for men is not clearly confirmed. This study evaluated the usefulness of intraurethral instillation of anesthetic jelly by questionnaires regarding the pain and uncomfortable feelings during and after the cystoscopic examination. A total of 62 men were enrolled in the study. Sixteen patients had not received cystoscopy previously (first cases), and 46 had prior experiences of cystoscopy more than twice (repeat cases). These patients were sequentially divided into two groups; one group (jelly-group) received intraurethral instillation of oxybuprocaine hydrochroride jelly (Benoxil jelly) prior to cystoscopic examination, and the other group (no-jelly-group) did not receive the jelly instillation. Pain during the jelly instillation to examination, and uncomfortable feelings at micturition after the examination was evaluated by questionnaires. Instillation of the jelly itself caused considerable pain, which almost similar to that of scope insertion. There was no significant difference in pain score between jelly-group and no-jelly-group during the insertion of the scope to examination. The miction pain after examination was significantly severer in the jelly-group than in the no-jelly-group in repeat cases. In addition, 75% of repeat cases felt better comfortableness when jelly was not instilled, and 96% of repeat cases did not want jelly instillation for their future examination. Intraurethral instillation of anesthetic jelly had no efficacy for reducing the pain during cystoscopy. Instillation of the jelly itself caused considerable pain, and it made pain and uncomfortable feelings after the examination worse. These results suggested that the instillation of anesthetic jelly before rigid cystoscopy in men might not be useful enough for reducing the uncomfortable feeling during the examination.
Read moreTherapeutic Application of Microbubble-Based Agents
H. D. Liang, PhD Department of Medical Physics and Bioengineering, Bristol General Hospital, Bristol, BS1 6SY, UK M. J. K. Blomley, MD Professor of Radiology and Joint Head, Imaging Sciences Department, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK D. O. Cosgrove, MD Professor of Clinical Ultrasound, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK Ultrasound is required and used to trace microbubbles. When targeted microbubbles reach the target site, US can be used to disrupt drug-loaded microbubbles to achieve site-specific delivery. Application of US to thin-shelled microbubbles flowing through microvessels is now known to induce vessel wall rupture in vivo (Skyba et al. 1998) large enough to permit extravasation of red blood cells (Price et al. 1998a). In a similar way targeted microbubbles can be disrupted with US, thereby allowing active substance out of the vascular pool and into specific tissue. Possibilities of targeted delivery of drug-loaded microbubbles and local release by US-triggered bubble destruction are particular assets for microbubbles. The combined capacities of microbubbles for disease detection and assessment, drug and gene targeting, triggered release, and assessment of therapy are unique. Microbubbles may also provide effective tools for drug development to determine the pharmacokinetics and pharmacodynamics of new molecules, determine dose regimen, and establish therapeutic efficacy.
Read moreFailure to care for heels
The patient was a type 1 diabetic subject under our care for 15 years; his many risk factors for foot ulceration included age, gender, living alone, neuropathy, PVD, structural deformity, previous ulceration1. He sustained a fracture of the neck of femur. Picture of rotten heel. Practical Diabetes International invite you to submit your favourite slide with clinical details for possible publication in this series.
Read moreDuplex and colour flow imaging
Definitions A duplex scanning system is one that enables two-dimensional ultrasonic pulse-echo imaging to guide the placement of an ultrasonic Doppler beam and thus to allow the anatomical location of the origin of the Doppler signals to be identified. Since its inception, the common usage of the term ‘duplex’ has changed; what most people now consider to be a duplex scanner is one that has real-time imaging capability with either the imaging transducer itself or, less commonly, a separate transducer being used to collect pulsed or, again less commonly, continuous wave Doppler signals. The processes of imaging and Doppler signal acquisition can either give the impression of being simultaneous or, less commonly, separate and sequential. A colour flow imaging system is one that superimposes information about flow (or structure motion), coded in colour, on a two-dimensional (or three-dimensional) greyscale image. Whilst this could be achieved by exploring the region-of-interest line-by-line or point-by-point (for example, with a duplex scanner) and representing the frequency or amplitude of the Doppler signals in pseudocolour, the modern use of the terminology is confined to real-time (or, at least, rapid) implementation of the process. History The history of the development of ultrasonic pulse-echo imaging, from the earliest demonstration of the medical application of the A-scope through to the advanced high resolution real-time grey-scale scanners of today, is already well documented (Wells, 1978; Goldberg & Kimmelman, 1988).
Read more6. Mild renal impairment with marked hyperkalaemia
This patient with type 2 diabetes was known to have diabetic nephropathy as evidenced by microalbuminuria, mild renal impairment and normal renal tract ultrasound. She had persistent marked hyperkalaemia ( ie not due to haemolysis of sample) despite only modest renal impairment; she was not on any drugs known to cause hyperkalaemia. Clinically this is type 4 renal tubular acidosis which can occur in subjects with diabetic nephropathy. This form of oxides is comprehensively reviewed by Penney and Oleesky1 who have given guidelines on the appropriate tests to perform. It should be regarded as “aldosterone deficiency or resistance”. Subjects with diabetic nephropathy have hyporeninaemic hypoaldosteronism. The common differential diagnosis is Addison's disease or the use of potassium sparing diuretics. There drugs, along with ACE inhibitors, can exacerbate the type 4 renal tubular acidosis of diabetic nephropathy. Treatment is primarily with fludrocortisone plus loop diuretic to induce renal potassium loss and prevent fluid retention from the fludrocortisone; with this therapy, our patient has had normal potassium levels. 1
Read moreMedical Physics and Biomedical Engineering